QA: Dermata Therapeutics Inc in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001853816_2022_Dermata_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}
warning Ignoring company because Expenses is zero pre-agg {'balance_sheet': {'company_id': '0001853816', 'EntityCommonStockSharesOutstanding': 12102214, 'Assets': 6944488, 'AssetsCurrent': 0, 'CostOfGoodsAndServicesSold': 0, 'Expenses': 0, 'IntangibleAssetsNetIncludingGoodwill': 0, 'Liabilities': 922634, 'LiabilitiesAndStockholdersEquity': 6944488, 'LiabilitiesCurrent': 496702, 'LiabilitiesNoncurrent': 0, 'NetIncome': -9610913, 'PropertyPlantAndEquipmentNet': 0, 'ResearchAndDevelopmentExpense': 0, 'Revenues': 0, 'SellingGeneralAndAdministrativeExpense': 0, 'remainder_Assets': 6944488, 'remainder_ComprehensiveNetIncome': 0, 'remainder_Expenses': 0, 'remainder_Liabilities': 425932, 'remainder_LiabilitiesAndStockholdersEquity': 6021854, 'remainder_NetIncome': -9610913, 'remainder_Revenues': 0, 'obs_EconomicCapitalRatio': nan}}

Graph

Absolute values for 0001853816, Dermata Therapeutics Inc

  xvar xval
0 AssetsCurrent 11,623,940
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 0
4 LiabilitiesCurrent 1,516,836
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 0
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses 45,613
11 remainder_Revenues 0
12 remainder_NetIncome -7,856,864
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 11,623,940
1 Liabilities 1,516,836
2 Expenses 45,613
3 Revenues 0
4 StockholdersEquity 10,107,104
5 NetIncome -7,902,477
6 ComprehensiveNetIncome -7,902,477
7 BaseVar 10,521,626
8 EconomicCapitalRatiobeforeLimitedLiability 2.15
9 EconomicCapitalRatio 3.12

Edgar->Model Mapping

Feature Distribution